| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.007 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.15 | 0.007 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.091 | 0.008 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.008 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.008 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.01 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |